Company Filing History:
1 out of 41 
1 out of 2 
1 out of 15,471 
Years Active: 2007-2018
Title: Hermann Koepsell: Innovator in Glucose Metabolism Research
Introduction
Hermann Koepsell, an accomplished inventor based in Höchberg, Germany, has made significant contributions to the field of glucose metabolism through his innovative research and patents. With a total of three patents to his name, Koepsell is recognized for his groundbreaking work in the development of peptide-based pharmaceuticals that aim to improve insulin sensitivity and regulate glucose absorption.
Latest Patents
Koepsell's latest inventions include a pharmaceutical composition comprising peptides derived from RS1, which serve to down-regulate glucose absorption after a glucose-rich meal while enhancing insulin sensitivity. His work focuses on a (poly)peptide that either comprises or consists of QEP or a QEP derivative, alongside its nucleic acid encoding. This composition is found to be beneficial for preventing or treating diseases linked to glucose and/or galactose uptake, particularly under high-sugar conditions.
Additionally, Koepsell's research includes the development of food compositions that utilize these (poly)peptides and methods to screen for compounds capable of preventing metabolic diseases associated with glucose uptake. He has also created a method for predicting patient responses to said peptides, establishing criteria for effective treatment approaches.
Koepsell's patent portfolio further encompasses tripeptides that down-regulate the activities of plasma membrane transporters, specifically sodium-D-glucose cotransporter SGLT1. This innovative work aims at preparing pharmaceutical compositions and food supplements that help ameliorate, prevent, or treat metabolic diseases linked with homeostatic modifications.
Career Highlights
Koepsell has been associated with notable research institutions like the Julius Maximilians University of Würzburg, where he has contributed his expertise in metabolic research and peptide chemistry. His career showcases a steadfast commitment to exploring the intersection of pharmacology and nutrition.
Collaborations
Throughout his journey, Koepsell has collaborated with esteemed colleagues such as Alexandra Friedrich and Jürgen Groll. These partnerships have enhanced the scope and impact of his research, fostering a collaborative environment that thrives on innovation.
Conclusion
As an inventor, Hermann Koepsell stands at the forefront of research aimed at tackling metabolic diseases through innovative peptide therapies. His patents not only reflect his ingenuity but also the potential for significant advancements in medical treatments related to glucose metabolism, positioning him as a valuable contributor to the scientific community.